Mitochondrial dynamics as a bridge between mitochondrial dysfunction and insulin resistance

Archives of Physiology and Biochemistry

Volumn 115, Issue 1, 2009, Pages 1-12

  Zorzano, Antonio ^a,b,c   Liesa, Marc ^a,b,c   Palacin, Manuel ^a,b  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Insulin resistance; Mitochondria; Mitochondrial dynamics; Mitofusin; Obesity; Type 2 diabetes

Indexed keywords

CALCINEURIN; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE IV; HEAT SHOCK PROTEIN; MEMBRANE PROTEIN; MFN2 PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PPARGC1A PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ANIMAL; ARTICLE; CYTOLOGY; HUMAN; INSULIN RESISTANCE; METABOLISM; MITOCHONDRION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKELETAL MUSCLE;

ANIMALS; CALCINEURIN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 4; DIABETES MELLITUS, TYPE 2; HEAT-SHOCK PROTEINS; HUMANS; INSULIN RESISTANCE; MEMBRANE PROTEINS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; MUSCLE, SKELETAL; OBESITY; PPAR DELTA; TRANSCRIPTION FACTORS;

EID: 62349083021     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450802676335     Document Type: Article

References (92)

1. Alexander C, Votruba M, Pesch UE, Thiselton DL, Mayer S, Moore A, Rodriguez M, Kellner U, Leo-Kottler B, Auburger G, et al. (2000). OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat Genet 26: 211-15.
2. Amchenkova AA, Bakeeva LE, Chentsov YS, Skulachev VP, Zorov DB. (1988). Coupling membranes as energy-transmitting cables. I. Filamentous mitochondria in fibroblasts and mitochondrial clusters in cardiomyocytes. J Cell Biol 107: 481-95.
3. Arany Z, He H, Lin J, Hoyer K, Handschin C, Toka O, Ahmad F, Matsui T, Chin S, Wu PH, et al. (2005). Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab 1: 259-71.
4. Arany Z, Lebrasseur N, Morris C, Smith E, Yang W, Ma Y, Chin S, and Spiegelman BM. (2007). The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibres in skeletal muscle. Cell Metab 5: 35-46.
5. Bach D, Naon D, Pich S, Soriano FX, Vega N, Rieusset J, Laville M, Guillet C, Boirie Y, Wallberg-Henriksson H, et al. (2005). Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss, and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes 54: 2685-93.
6. Bach D, Pich S, Soriano FX, Vega N, Baumgartner B, Oriola J, Daugaard JR, Lloberas J, Camps M, Zierath JR, et al. (2003). Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem 278: 17190-97.
7. Bakeeva LE, Chentsov YS, Skulachev VP. (1978). Mitochondrial framework (reticulum mitochondrial) in rat diaphragm muscle. Biochimica et Biophysica Acta 501: 349-369.
8. Bakeeva LE, Chentsov YS, Skulachev VP. (1981). Ontogenesis of mitochondrial reticulum in rat diaphragm muscle. Euro J Cell Biol 25: 175-81.
9. Bereiter-Hahn J, Voth M. (1994). Dynamics of mitochondria in living cells: shape changes, dislocations, fusion, and fission of mitochondria. Microsc Res Tech 27: 198-219.
10. Bonnard C, Durand A, Peyrol S, Chanseaume E, Chauvin MA, Morio B, Vidal H, and Rieusset J. (2008). Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J Clin Invest 118: 789-800.
11. Boushel R, Gnaiger E, Schjerling P, Skovbro M, Kraunsoe R, and Dela F. (2007). Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle. Diabetologia 50: 790-96.
12. Chen H, Chomyn A, Chan DC. (2005). Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem 280: 26185-92.
13. Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE, Chan DC. (2003). Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 160: 189-200.
14. Chen KH, Guo X, Ma D, Guo Y, Li Q, Yang D, Li P, Qiu X, Wen S, Xiao RP, et al. (2004). Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol 6: 872-83.
15. Chin ER, Olson EN, Richardson JA, Yang Q, Humphries C, Shelton JM, Wu H, Zhu W, Bassel-Duby R, Williams RS. (1998). A calcineurin-dependent transcriptional pathway controls skeletal muscle fibre type. Genes Dev 12: 2499-509.
16. Cipolat S, Rudka T, Hartmann D, Costa V, Serneels L, Craessaerts K, Metzger K, Frezza C, Annaert W, D'Adamio L, et al. (2006). Mitochondrial rhomboid PARL regulates cytochrome c release during apoptosis via OPA1-dependent cristae remodeling. Cell 126: 163-75.
17. Cogswell AM, Stevens RJ, Hood DA. (1993). Properties of skeletal muscle mitochondria isolated from subsarcolemmal and intermyofibrillar regions. Am J Physiol 264: C383-9.
18. Cortese JD. (1998). Stimulation of rat liver mitochondrial fusion by an outer membrane-derived aluminum fluoride-sensitive protein fraction. Exp Cell Res 240: 122-33.
19. Delettre C, Lenaers G, Griffoin JM, Gigarel N, Lorenzo C, Belenguer P, Pelloquin L, Grosgeorge J, Turc-Carel C, Perret E, et al. (2000). Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy. Nat Genet 26: 207-10.
20. Dressel U, Allen TL, Pippal JB, Rohde PR, Lau P, Muscat GE. (2003). The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol Endocrinol 17: 2477-93.
21. Fawcett KA, Wareham NJ, Luan J, Syddall H, Cooper C, O'Rahilly S, Day IN, Sandhu MS, Barroso I. (2006). PARL Leu262Val is not associated with fasting insulin levels in UK populations. Diabetologia 49: 2649-52.
22. Felber JP, Ferrannini E, Golay A, Meyer HU, Theibaud D, Curchod B, Maeder E, Jequier E, and DeFronzo RA. (1987). Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes. Diabetes 36: 1341-50.
23. Frezza C, Cipolat S, Martins dB, Micaroni M, Beznoussenko GV, Rudka T, Bartoli D, Polishuck RS, Danial NN, De Strooper B, et al. (2006). OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell 126: 177-89.
24. Gastaldi G, Russell A, Golay A, Giacobino JP, Habicht F, Barthassat V, Muzzin P, Bobbioni-Harsch E. (2007). Upregulation of peroxisome proliferator-activated receptor gamma coactivator gene (PGC1A) during weight loss is related to insulin sensitivity but not to energy expenditure. Diabetologia 50: 2348-55.
25. Griparic L, van der Wel NN, Orozco IJ, Peters PJ, van der Bliek AM. (2004). Loss of the intermembrane space protein Mgm1/OPA1 induces swelling and localized constrictions along the lengths of mitochondria. J Biol Chem 279: 18792-8.
26. Guillery O, Malka F, Landes T, Guillou E, Blackstone C, Lombes A, Belenguer P, Arnoult D, Rojo M. (2008). Metalloproteasemediated OPA1 processing is modulated by the mitochondrial membrane potential. Biol Cell 100: 315-25.
27. Hales KG, Fuller MT. (1997). Developmentally regulated mitochondrial fusion mediated by a conserved, novel, predicted GTPase. Cell 90: 121-9.
28. Handschin C, Choi CS, Chin S, Kim S, Kawamori D, Kurpad AJ, Neubauer N, Hu J, Mootha VK, Kim YB, Kulkarni RN, Shulman GI, Spiegelman BM. (2007). Abnormal glucose homeostasis in skeletal muscle-specific PGC-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk. J Clin Invest 117: 3463-74.
29. Hondares E, Pineda-Torra I, Iglesias R, Staels B, Villarroya F, and Giralt M. (2007). PPARdelta, but not PPARalpha, activates PGC-1alpha gene transcription in muscle. Biochem Biophys Res Commun 354: 1021-7.
30. Huss JM, Kopp RP, Kelly DP. (2002). Peroxisome proliferatoractivated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogenrelated receptor-alpha and -gamma. Identification of novelleucine-rich interaction motif within PGC-1alpha. J Biol Chem 277: 40265-74.
31. Ishihara N, Fujita Y, Oka T, Mihara K. (2006). Regulation of mito chondrial morphology through proteolytic cleavage of OPA1. EMBO J 25: 2966-77.
32. James DI, Parone PA, Mattenberger Y, Martinou JC. (2003). hFis1, a novel component of the mammalian mitochondrial fission machinery. J Biol Chem 278: 36373-9.
33. Jofuku A, Ishihara N, Mihara K. (2005). Analysis of functional domains of rat mitochondrial Fis1, the mitochondrial fission-stimulating protein. Biochem Biophys Res Commun 333: 650-59.
34. Kamei Y, Ohizumi H, Fujitani Y, Nemoto T, Tanaka T, Takahashi N, Kawada T, Miyoshi M, Ezaki O, and Kakizuka A. (2003). PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity. Proc Natl. Acad Sci USA 100: 12378-83.
35. Kelley DE, Goodpaster B, Wing RR, Simoneau JA. (1999). Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity and weight loss. Am J Physiol 277: E1130-41.
36. Kelley DE, He J, Menshikova EV, Ritov VB. (2002). Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51: 2944-50.
37. Kelley DE, Mandarino LJ. (2000). Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49: 677-83.
38. Legros F, Lombes A, Frachon P, Rojo M. (2002). Mitochondrial fusion in human cells is efficient, requires the inner membrane potential, and is mediated by mitofusins. Mol Biol Cell 13: 4343-54.
39. Lelliott CJ, Medina-Gomez G, Petrovic N, Kis A, Feldmann HM, Bjursell M, Parker N, Curtis K, Campbell M, Hu P et al. (2006). Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol 4: e369.
40. Leone TC, Lehman JJ, Finck BN, Schaeffer PJ Wende AR, Boudina S, Courtois M, Wozniak DF, Sambandam N, Bernal-Mizrachi C, et al. (2005). PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol 3: e101. Lewis MR, Lewis WH. (1914). Mitochondria in tissue culture. Science 39: 330-33.
41. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C. (1993). Insulin resistance and insulin secretory dysfunction as precursors of noninsulin-dependent diabetes mellitus. Prospective studies of Pima Indians. N Engl J Med 329: 1988-92.
42. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, et al. (2002). Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418: 797-801.
43. Lin J, Wu PH, Tarr PT, Lindenberg KS, St Pierre J, Zhang CY, Mootha VK, Jager S, Vianna CR, Reznick RM, et al. (2004). Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice. Cell 119: 121-35.
44. Malka F, Guillery O, Cifuentes-Diaz C, Guillou E, Belenguer P, Lombes A, Rojo M. (2005). Separate fusion of outer and inner mitochondrial membranes. EMBO Rep 6: 853-9.
45. McCullagh KJ, Calabria E, Pallafacchina G, Ciciliot S, Serrano AL, Argentini C, Kalhovde JM, Lomo T, Schiaffino S. (2004). NFAT is a nerve activity sensor in skeletal muscle and controls activity-dependent myosin switching. Proc Natl Acad Sci USA 101: 10590-95.
46. Meeusen S, McCaffery JM, Nunnari J. (2004). Mitochondrial fusion intermediates revealed in vitro. Science 305: 1747-52.
47. Mingrone G, Manco M, Calvani M, Castagneto M, Naon D, Zorzano A. 2005 Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity?. Diabetologia 48: 2108-14.
48. Mogensen M, Sahlin K, Fernstrom M, Glintborg D, Vind BF, Beck-Nielsen H, and Hojlund K. (2007). Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 56: 1592-9.
49. Mootha VK, Handschin C, Arlow D, Xie X, St Pierre J, Sihag S, Yang W, Altshuler D, Puigserver P, Patterson N, et al. (2004). Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. Proc Natl Acad Sci USA 101: 6570-75.
50. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, et al. (2003). PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-73.
51. Murgia M, Serrano AL, Calabria E, Pallafacchina G, Lomo T, Schiaffino S. (2000). Ras is involved in nerve-activity-dependent regulation of muscle genes. Nat Cell Biol 2: 142-7.
52. Naya FJ, Mercer B, Shelton J, Richardson JA, Williams RS, Olson EN. (2000). Stimulation of slow skeletal muscle fibre gene expression by calcineurin in vivo. J Biol Chem 275: 4545-8.
53. Nunnari J, Marshall WF, Straight A, Murray A, Sedat JW, Walter P. (1997). Mitochondrial transmission during mating in Saccharomyces cerevisiae is determined by mitochondrial fusion and fission and the intramitochondrial segregation of mitochondrial DNA. Mol Biol Cell 8: 1233-42.
54. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S, Miyazaki Y, Kohane I, Costello M, Saccone R, et al. (2003). Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proceedings of the National Academy of Sciences of the United States of America 100: 8466-71.
55. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI. (2003). Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300: 1140-42.
56. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. (2004). Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664-71.
57. Pich S, Bach D, Briones P, Liesa M, Camps M, Testar X, Palacin M, Zorzano A. (2005). The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum Mol Genet 14: 1405-15 .
58. Pospisilik JA, Knauf C, Joza N, Benit P, Orthofer M, Cani PD, Ebersberger I, Nakashima T, Sarao R, Neely G, et al. (2007). Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell 131: 476-91.
59. Potthoff MJ, Wu H, Arnold MA, Shelton JM, Backs J, McAnally J, Richardson JA, Bassel-Duby R, Olson EN. (2007). Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibres. J Clin Invest 117: 2459-67.
60. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. (1998). A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92: 829-39.
61. Ritov, VB, Menshikova, EV, He, J, Ferrell, RE, Goodpaster, BH, Kelley, DE. (2005). Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 54: 8-14.
62. Santel A, Frank S, Gaume B, Herrler M, Youle RJ, Fuller MT. (2003). Mitofusin-1 protein is a generally expressed mediator of mitochondrial fusion in mammalian cells. J Cell Sci 116: 2763-74.
63. Santel A, Fuller MT. (2001). Control of mitochondrial morphology by a human mitofusin. J Cell Sci 114: 867-74.
64. Schuler M, Ali F, Chambon C, Duteil D, Bornert JM, Tardivel A, Desvergne B, Wahli W, Chambon P, Metzger D. (2006). PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fibre-type switching obesity, and type 2 diabetes. Cell Metab 4: 407-14.
65. Serrano AL, Murgia M, Pallafacchina G, Calabria E, Coniglio P, Lomo T, Schiaffino S. (2001). Calcineurin controls nerve activity-dependent specification of slow skeletal muscle fibres but not muscle growth. Proc Natl Acad Sci USA 98: 13108-13.
66. Skulachev VP. (2001). Mitochondrial filaments and clusters as\ intracellular power-transmitting cables. Trends Biochem. Sci 26: 23-9.
67. Smirnova E, Shurland DL, Ryazantsev SN, van der Bliek AM. (1998). A human dynamin-related protein controls the distribution of mitochondria. J Cell Biol 143: 351-8.
68. Song Z, Chen H, Fiket M, Alexander C, Chan DC. (2007). OPA1 processing controls mitochondrial fusion and is regulated by mRNA splicing, membrane potential, and Yme1L. J Cell Biol 178: 749-55.
69. Sonoda J, Mehl IR, Chong LW, Nofsinger RR, Evans RM. (2007). PGC-1beta controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis. Proc Natl Acad Sci USA 104: 5223-8.
70. St Pierre J, Lin J, Krauss S, Tarr PT, Yang R, Newgard CB, Spiegelman BM. (2003). Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem 278: 26597-603.
71. Staiger H, Stefan N, Machicao F, Fritsche A, Haring HU. (2006). PPARGC1A mRNA levels of in vitro differentiated human skeletal muscle cells are negatively associated with the plasma oleate concentrations of the donors. Diabetologia 49: 212-14.
72. Storlien L, Oakes ND, Kelley DE. (2004). Metabolic flexibility. Proc Nutr Soc 63: 363-8.
73. Thomas DY, Wilkie D. (1968). Recombination of mitochhondrial drug-resistance factor in saccharomyces cerevisiae. Bioch Biophys Res Comm 30: 368-72.
74. Toledo FG, Watkins S, Kelley DE. (2006). Changes induced by physical activity and weight loss in the morphology of intermyofibrillar mitochondria in obese men and women. J Clin Endocrinol Metab 91: 3224-7.
75. Tondera D, Czauderna F, Paulick K, Schwarzer R, Kaufmann J, Santel A. (2005). The mitochondrial protein MTP18 contributes to mitochondrial fission in mammalian cells. J Cell Sci 118: 3049-59.
76. Tondera D, Santel A, Schwarzer R, Dames S, Giese K, Klippel A, Kaufmann J. (2004). Knockdown of MTP18, a novel phosphatidylinositol 3-kinase-dependent protein, affects mitochondrial morphology and induces apoptosis. J Biol Chem 279: 31544-55.
77. van den Ouweland JM, Ruitenbeek W, Lemkes HH, Ruitenbeek W, Sandkuijl LA, de Vijlder MF, Struyvenberg PA, van de Kamp JJ, Maassen JA. (1992). Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1: 368-71.
78. Vianna CR, Huntgeburth M, Coppari R, Choi CS, Lin J, Krauss S, Barbatelli G, Tzameli I, Kim YB, Cinti S, et al. (2006). Hypomorphic mutation of PGC-1beta causes mitochondrial dysfunction and liver insulin resistance. Cell Metab 4: 453-64.
79. Wakabayashi T, Asano M, Kurono C. (1975). Mechanism of the formation of megamitochondria induced by copperchelating agents. I. On the formation process of megamitochondria in cuprizone-treated mouse liver. Acta Pathol Jpn 25: 15-37.
80. Wakabayashi T, Green DE. (1977). Membrane fusion in mitochondria. I. Ultrastructural basis for fusion. J Electron Microsc (Tokyo) 26: 305-20.
81. Walder K, Kerr-Bayles L, Civitarese A, Jowett J, Curran J, Elliott K, Trevaskis J, Bishara N, Zimmet P, Mandarino L, et al. (2005). The mitochondrial rhomboid protease PSARL is a new candidate gene for type 2 diabetes. Diabetologia 48: 459-68.
82. Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H, Evans RM. (2004). Regulation of muscle fibre type and running endurance by PPARdelta. PLoS Biol 2: e294.
83. Wasiak S, Zunino R, McBride HM. (2007). Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death. J Cell Biol 177: 439-50.
84. Wredenberg A, Freyer C, Sandstrom ME, Katz A, Wibom R, Westerblad H, Larsson NG. (2006). Respiratory chain dysfunction in skeletal muscle does not cause insulin resistance. Biochem Biophys Res Commun 350: 202-7.
85. Wu H, Kanatous SB, Thurmond FA, Gallardo T, Isotani E, Bassel-Duby R, Williams RS. (2002). Regulation of mitochondrial biogenesis in skeletal muscle by CaMK. Science 296: 349-52.
86. Wu H, Naya FJ, McKinsey TA, Mercer B, Shelton JM, Chin ER, Simard AR, Michel RN, Bassel-Duby R, Olson EN, et al. (2000). MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fibre type. EMBO J 19: 1963-73.
87. Wu H, Rothermel B, Kanatous S, Rosenberg P, Naya FJ, Shelton JM, Hutcheson KA, DiMaio JM, Olson EN, Bassel-Duby R, et al. (2001). Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J 20: 6414-23.
88. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, and Spiegelman BM. (1999). Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98: 115-24.
89. Yaffe MP. (1999). The machinery of mitochondrial inheritance and behavior. Science 283: 1493-7.
90. Yoon Y, Krueger EW, Oswald BJ, McNiven MA. (2003). The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynaminlike protein DLP1. Mol Cell Biol 23: 5409-20.
91. Yoon Y, Pitts KR, Dahan S, McNiven MA. (1998). A novel dynamin-like protein associates with cytoplasmic vesicles and tubules of the endoplasmic reticulum in mammalian cells. J Cell Biol 140: 779-93.
92. Zuchner S, Mersiyanova IV, Muglia M, Bissar-Tadmouri N, Rochelle J, Dadali EL, Zappia M, Nelis E, Patitucci A, Senderek J, et al. (2004). Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nature Genetics 36: 449-51.